Regulatory and
Study Stage Index
The furthest regulatory or registered-study stage on record for each compound, from preclinical work to a marketing authorisation. A stage describes a regulatory record. It says nothing about what any study found.
Approved in the United States
(57)At least one medicinal product containing the compound holds a US marketing authorisation. This is a fact about that product's regulatory record. It does not describe any material sold for research.
GLP-1 SM
GLP-1 receptor agonist
Approval recorded: United States, Canada, United Kingdom, European Union, Australia
GLP-2 TZ
GIP and GLP-1 receptor dual agonist
Approval recorded: United States, Canada, United Kingdom, European Union, Australia
PT-141
Melanocortin receptor agonist (MC3R / MC4R)
Approval recorded: United States
Tesamorelin
GHRH analogue (GHRH receptor agonist)
Approval recorded: United States, Canada
Gonadorelin
Peptide hormone
SS-31
Mitochondrial peptide
Approval recorded: United States
GLP-1 LR
GLP-1 receptor agonist
Approval recorded: United States, Canada, United Kingdom, European Union, Australia
Exenatide
GLP-1 receptor agonist
Approval recorded: United States, Canada, United Kingdom, European Union, Australia
GLP-1 DG
GLP-1 receptor agonist
Approval recorded: United States, Canada, United Kingdom, European Union, Australia
Lixisenatide
GLP-1 receptor agonist
Approval recorded: United States, Canada, United Kingdom, European Union, Australia
Pramlintide
Amylin analogue
Approval recorded: United States
Calcitonin (Salmon)
Approval recorded: United States, Canada, Australia
Setmelanotide
Approval recorded: United States, Canada, United Kingdom, European Union, Australia
Oxytocin
Peptide hormone
Approval recorded: United States, Canada, United Kingdom, European Union, Australia
Vasopressin
Peptide hormone
Approval recorded: United States, Canada, Australia
Desmopressin
Peptide hormone
Approval recorded: United States, Canada, United Kingdom, European Union, Australia
Terlipressin
Peptide hormone
Approval recorded: United States, United Kingdom, European Union, Australia
Leuprolide
Peptide hormone
Approval recorded: United States, Canada, United Kingdom, European Union, Australia
Goserelin
Peptide hormone
Approval recorded: United States, Canada, United Kingdom, European Union, Australia
Triptorelin
Peptide hormone
Approval recorded: United States, Canada, United Kingdom, European Union, Australia
Nafarelin
Peptide hormone
Approval recorded: United States, Canada, United Kingdom, European Union, Australia
Histrelin
Peptide hormone
Approval recorded: United States, Canada, Australia
Degarelix
Peptide hormone
Approval recorded: United States, Canada, United Kingdom, European Union, Australia
Ganirelix
Peptide hormone
Approval recorded: United States, Canada, United Kingdom, European Union, Australia
Cetrorelix
Peptide hormone
Approval recorded: United States, Canada, United Kingdom, European Union, Australia
Macimorelin
Growth hormone secretagogue receptor (GHS-R1a) agonist
Approval recorded: United States, European Union
Growth Hormone
Approval recorded: United States, Canada, United Kingdom, European Union, Australia
IGF-1
IGF-1 analogue
Approval recorded: United States, European Union
Angiotensin II
Approval recorded: United States
Nesiritide
Approval recorded: United States
Octreotide
Approval recorded: United States, Canada, United Kingdom, European Union, Australia
Lanreotide
Approval recorded: United States, Canada, United Kingdom, European Union, Australia
Pasireotide
Approval recorded: United States, Canada, United Kingdom, European Union, Australia
Glucagon
Approval recorded: United States, Canada, United Kingdom, European Union, Australia
Teduglutide
Approval recorded: United States, Canada, United Kingdom, European Union, Australia
Plecanatide
Approval recorded: United States
Linaclotide
Approval recorded: United States, Canada, United Kingdom, European Union, Australia
Abaloparatide
Approval recorded: United States, Canada
Teriparatide
Approval recorded: United States, Canada, United Kingdom, European Union, Australia
PTH (Parathyroid Hormone)
Approval recorded: United States, Canada, United Kingdom
Afamelanotide
Melanocortin receptor agonist
Approval recorded: United States, United Kingdom, European Union, Australia
Bremelanotide
Melanocortin receptor agonist (MC3R / MC4R)
Approval recorded: United States
Difelikefalin
Approval recorded: United States, Canada, United Kingdom, European Union, Australia
Ziconotide
Approval recorded: Canada, United Kingdom, European Union, Australia
Romiplostim
Approval recorded: United States, Canada, United Kingdom, European Union, Australia
Enfuvirtide
Approval recorded: United States, Canada, United Kingdom, European Union, Australia
Icatibant
Approval recorded: United States, Canada, United Kingdom, European Union, Australia
Eptifibatide
Approval recorded: United States, Canada, United Kingdom, European Union, Australia
Bivalirudin
Approval recorded: United States, Canada, United Kingdom, European Union, Australia
Desirudin
Approval recorded: United States
HCG
Glycoprotein hormone
Approval recorded: United States, Australia
L-Carnitine
Approval recorded: United States
HGH 191AA
Recombinant human growth hormone (191 residues)
Approval recorded: United States
Melanotan I (Afamelanotide)
Melanocortin 1 receptor agonist
Approval recorded: United States, European Union, Australia
TRH (Thyrotropin-Releasing Hormone)
Approval recorded: United States, European Union
Somatropin (rHGH)
Recombinant human growth hormone (191 residues)
Approval recorded: United States
HMG
Approval recorded: United States, Canada, United Kingdom, European Union, Australia
Approved Outside the United States
(14)A national medicines regulator outside the United States has authorised a product containing the compound. There is no US authorisation.
GHRP-2
Growth hormone secretagogue receptor (GHS-R1a) agonist
Thymosin Alpha-1
Selank
Semax
Cerebrolysin
Approval recorded: European Union
Mazdutide
GLP-1 and glucagon receptor dual agonist
Carbetocin
Peptide hormone
Approval recorded: Canada, United Kingdom, European Union, Australia
Buserelin
Peptide hormone
Approval recorded: Canada, United Kingdom, European Union, Australia
Oligopeptide-1 / EGF
Noopept
Thymalin
Bioregulator (thymic)
Thymogen
Anamorelin
Growth hormone secretagogue receptor (GHS-R1a) agonist
Demoxytocin
Approval Withdrawn
(2)A marketing authorisation was held and has since been withdrawn or discontinued.
Sermorelin
GHRH analogue (GHRH receptor agonist)
Albiglutide
GLP-1 receptor agonist
Phase III
(20)The furthest registered human study stage recorded is Phase III. No authorisation is recorded.
Pemvidutide
GLP-1 and glucagon receptor dual agonist
Cotadutide
GLP-1 and glucagon receptor dual agonist
Danuglipron
Orforglipron
Thymosin Beta-4
Larazotide
Pexiganan
Cathelicidin antimicrobial peptide
Omiganan
Cathelicidin antimicrobial peptide
Brilacidin
Cathelicidin antimicrobial peptide
AICAR
Enclomiphene
Selective estrogen receptor modulator (non-peptide)
Tesofensine
Amycretin
Human Relaxin-2
Phase II
(15)The furthest registered human study stage recorded is Phase II. No authorisation is recorded.
BPC-157
View research materialAOD-9604
View research materialHexarelin
Growth hormone secretagogue receptor (GHS-R1a) agonist
Follistatin 344
IGF-1 analogue
Tabimorelin
Growth hormone secretagogue receptor (GHS-R1a) agonist
IM862
PACAP
Neuropeptide
Myostatin Propeptide
Trevogrumab
Phase I
(1)The furthest registered human study stage recorded is Phase I. No authorisation is recorded.
Preclinical or No Registered Phase
(124)No registered human study phase and no authorisation is recorded. Published work is laboratory and animal research.
TB-500
View research materialCJC-1295
GHRH analogue (GHRH receptor agonist)
Dihexa
View research materialKisspeptin
Peptide hormone
FOXO4-DRI
View research materialArgireline
5-Amino-1MQ
View research materialAmylin
Alexamorelin
Growth hormone secretagogue receptor (GHS-R1a) agonist
MGF
IGF-1 analogue
IGF-1 DES
IGF-1 analogue
Collagen Peptides
Matrixyl
Matrixyl 3000
Snap-8
View research materialPalmitoyl Tripeptide-1
Palmitoyl Tetrapeptide-7
Palmitoyl Tripeptide-5
Copper Tripeptide-1
Acetyl Tetrapeptide-5
Tripeptide-29
Myristoyl Pentapeptide-17
Biotinoyl Tripeptide-1
Sh-Polypeptide-1
Thymulin
Beta-Defensins
Cathelicidin antimicrobial peptide
Alpha-Defensins
Cathelicidin antimicrobial peptide
Lactoferricin
Cathelicidin antimicrobial peptide
Melittin
Cathelicidin antimicrobial peptide
Histatin-5
Cathelicidin antimicrobial peptide
Pinealon
View research materialCortagen
View research materialN-Acetyl Semax Amidate
PE-22-28
View research materialSubstance P
Neuropeptide
Neuropeptide Y
Neuropeptide
Angiotensin 1-7
Bradykinin
Atrial Natriuretic Peptide
B-type Natriuretic Peptide
Endothelin-1
Apelin
Adrenomedullin
Somatostatin
Calcitonin Salmon
PNC-27
Neuroxelin
Vilon
Bioregulator (thymic)
Livagen
Bronchogen
Pancragen
Vesilute
Bioregulator
Testagen
Prostamax
Chonluten
Tat-Beclin 1
AHK (Ala-His-Lys)
Copper-binding tripeptide
B7-33
Cartalax
Decapeptide-12
FGL(S)
Follistatin-315
Activin receptor IIB Fc fusion (ligand trap)
GHK (Glycyl-Histidyl-Lysine)
Melanostatin-DM (Nonapeptide-2)
N-Acetyl Epithalon Amidate
N-Acetyl Selank Amidate
Nonapeptide-1
OS-01 (OneSkin Peptide)
Ovagen
Pentapeptide-18 (Leuphasyl)
Rigin (Palmitoyl Tetrapeptide-7)
SYN-AKE
SYN-COLL (Palmitoyl Tripeptide-5)
TB-500 Fragment 17-23
Thymagen
Vialox (Pentapeptide-3)
Pal-GHK (Palmitoyl Tripeptide-1)
Dermorphin
Follistatin
FOXO4-DRI
GHK
Pal-AHK
Palmitoyl Dipeptide-6
PGPIPN
DS-5
BPC-157 + TB-500
CAGRILINTIDE + GLP-1 SM
Amylin receptor agonist
PTD-DBM
Acetyl Tetrapeptide-3
GDF-11
P21
Cholecystokinin (CCK)
Neuromedin U
Peptide YY (PYY)
Uroguanylin
CGRP
Cerluten
Kristagen
9-Me-BC
Astressin-B
Zhenoluten
Cortexin
Ghrelin
Growth hormone secretagogue receptor (GHS-R1a) agonist
GLP-1
Prostatilen
Retinalamin
BAM-15
About this index: Stages are compiled from public regulator and trial-registry records and may not reflect the most recent decisions. A stage describes the regulatory record of a compound, never a product sold here. All Volta Peptides material is supplied for laboratory research use only and is not for human consumption.
